Table 6.
Detailed results of final pathology for Category 6–4 (malignant, both grade and histology established)
| FNAC diagnosis (Category 6–4; n = 65) | ||||||||
|---|---|---|---|---|---|---|---|---|
| MEC | Ca ex pleo | AdCC | ACC | SCC | BCC | EMC | ||
| Low, intermediate-grade/high-grade | 36/29 | 4/13 | 0/1 | 12/8 | 18/0 | 0/7 | 1/0 | 1/0 |
| Final pathology | ||||||||
| Malignant(histology/grade) correct |
40(61.5%) 23/17 |
3/6 | 0/1 | 8/3 | 12/0 | 0/7 | 0 | 0 |
| Malignant(grade) correct |
18(27.7%) 6/12 |
1/7 | 0/0 | 2/5 | 2/0 | 0 | 0 | 1/0 |
| Malignant(only) correct |
3(4.6%) 3/0 |
0/0 | 0/0 | 1/0 | 2/0 | 0 | 0 | 0 |
| Benign |
4(6.2%) 4/0 |
1/0 | 2/0 | 1/0 | ||||
ACC acinic cell carcinoma, AdCC adenoid cystic carcinoma, BCC basal cell adenocarcinoma, Ca ex pleo carcinoma ex pleomorphic adenoma, EMC epithelial − myoepithelial carcinoma, FNAC fine-needle aspiration cytology, MEC mucoepidermoid carcinoma, SCC squamous cell carcinoma, SDC salivary duct carcinoma